Massachusetts General Laws
Chapter 94c - Controlled Substances Act
Section 31 - Classes of Controlled Substances; Establishment of Criminal Penalties for Violations of This Chapter

Section 31. For the purposes of establishing criminal penalties for violation of a provision of this chapter, there are established the following five classes of controlled substances:
CLASS A
(a) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:
(1) Acetylmethadol
(2) Allylprodine
(3) Alphacetylmethadol
(4) Alphameprodine
(5) Alphamethadol
(6) Benzethidine
(7) Betacetylmethadol
(8) Betameprodine
(9) Betamethadol
(10) Betaprodine
(11) Clonitazene
(12) Dextromoramide
(13) Dextrorphan
(14) Diampromide
(15) Diethylthiambutene
(16) Dimenoxadol
(17) Dimepheptanol
(18) Dimethylthiambutene
(19) Dioxaphetylbutyrate
(20) Dipipanone
(21) Ethylmethylthiambutene
(22) Etonitazene
(23) Etoxeridine
(24) Furethidine
(25) Hydroxypethidine
(26) Ketobemidone
(27) Levomoramide
(28) Levophenacylmorphan
(29) Morpheridine
(30) Noracymethadol
(31) Norlevorphanol
(32) Normethadone
(33) Norpipanone
(34) Phenadoxone
(35) Phenampromide
(36) Phenomorphan
(37) Phenoperidine
(38) Piritramide
(39) Proheptazine
(40) Properidine
(41) Racemoramide
(42) Trimeperidine
(b) Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Acetorphine
(2) Acetyldihydrocodeine
(3) Benzylmorphine
(4) Codeine methylbromide
(5) Codeine–N–Oxide
(6) Cyprenorphine
(7) Desomorphine
(8) Dihydromorphine
(9) Etorphine
(10) Heroin
(11) Hydromorphinol
(12) Methyldesorphine
(13) Methylhydromorphine
(14) Morphine methylbromide
(15) Morphine methylsulfonate
(16) Morphine–N–Oxide
(17) Myrophine
(18) Nicocodeine
(19) Nicomorphine
(20) Normorphine
(21) Pholcodine
(22) Thebacon
(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designations:
(1) Flunitrazepam
(2) Gamma Hydroxy Butyric Acid
(3) Ketamine.
[Paragraph (d) of Class A applicable as provided by 2018, 69, Sec. 237.]
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designations:
(1) Acetyl Fentanyl
(2) Carfentanil
(3) Fentanyl
(4) Cyclopropyl fentanyl
(5) Furanyl fentanyl
(6) 3–methylfentanyl
(7) 3,4–Dichloro–N–[2–(dimethylamino)cyclohexyl]–N–methylbenzamide
(8) Any synthetic opioid controlled in Schedule I of 21 C.F.R. 1308.11 or Schedule II of 21 C.F.R. 1308.12, unless specifically excepted or unless listed in another class in this section.
CLASS B
(a) Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate
(2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1) except that these substances shall not include the isoquinoline alkaloids of opium
(3) Opium poppy and poppy straw
(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine.
(5) Phenyl–2–Propanone (P2P)
(6) Phenylcyclohexylamine (PCH)
(7) Piperidinocyclohexanecarbonitrile (PCC)
(8) 3,4–methylenedioxy methamphetamine (MDMA).
(b) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including isomers, esters, ethers, salts, and salts of isomer, esters, and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:
[Clauses (1) to (20) of paragraph (b) of Class B applicable as provided by 2018, 69, Sec. 237.]
(1) Alphaprodine
(2) Anileridine
(3) Bezitramide
(4) Dihydrocodeine
(5) Diphenoxylate
(6) Isomethadone
(7) Levomethorphan
(8) Levorphanol
(9) Metazocine
(10) Methadone
(11) Methadone–Intermediate, 4–cyano–2–dimethylamino–4, 4–diphenyl butane
(12) Moramide–Intermediate, 2–methyl–3 morpholine–1, 1–diphenyl–propane carboxylic acid
(13) Pethidine
(14) Pethidine–Intermediate–A, 4–cyano–1–methyl–4–phenylpiperidine
(15) Pethidine–Intermediate–B, ethyl–4–phenylpiperidine–4–carboxylate
(16) Pethidine–Intermediate–C, 1–methyl–4–phenylpiperidine–4–carboxylic acid
(17) Phenazocine
(18) Piminodine
(19) Racemethorphan
(20) Racemorphan
(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
(1) Amphetamine, its salts, optical isomers and salts of its optical isomers.
(2) Any substance which contains any quantity of methamphetamine, including its salts, isomers and salts of isomers.
(3) Phenmetrazine and its salts.
(4) Methylphenidate.
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
(1) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid.
(2) Any substance which contains any quantity of methaqualone, or any salt or derivative of methaqualone.
(e) Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Lysergic acid
(2) Lysergic acid amide
(3) Lysergic acid diethylamide
(4) Phencyclidine.
CLASS C
(a) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
(1) Chlordiazepoxide
(2) Chlorhexadol
(3) Clonazepam
(4) Clorazepate
(5) Diazepam
(6) Flurazepam
(7) Glutethimide
(8) Lorazepam
(9) Methyprylon
(10) Oxazepam
(11) Prazepam
(12) Sulfondiethylmethane
(13) Sulfonethylmethane
(14) Sulfonmethane
(15) Temazepam.
(b) Nalorphine
(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
(1) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit with an equal or greater quantity of an isoquinoline alkaloid of opium.
(2) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(3) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.
(4) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
(5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
(6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(8) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
[There is no paragraph (d).]
(e) Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) 3, 4–methylenedioxy amphetamine
(2) 5–methoxy–3, 4–methylenedioxy amphetamine
(3) 3, 4, 5–trimethoxy amphetamine
(4) Bufotenine
(5) Diethyltryptamine
(6) Dimethyltryptamine
(7) 4–methyl–2, 5–dimethoxyamphetamine
(8) Ibogaine
(9) Mescaline
(10) Peyote
(11) N–ethyl–3–piperidyl benzilate
(12) N–methyl–3–piperidyl benzilate
(13) Psilocybin
(14) Psilocyn
(15) Tetrahydrocannabinols
(16) 4–Bromo–2, 5–Dimethoxy-amphetamine.
(17) 3, 4—methylenedioxymethcathinone, MDMC
(18) 3, 4—methylenedioxypyrovalerone, MDPV
(19) 4—methylmethcathinone, 4–MMC
(20) 4—methoxymethcathinone, bk–PMMA, PMMC
(21) 3, 4—fluoromethcathinone, FMC
(22) Napthylpyrovalerone, NRG–1
(23) Beta-keto–N–methylbenzodioxolylpropylamine
(24) 2–(methylamino)-propiophenone; OR alpha-(methylamino) propiophenone
(25) 3–methoxymethcathinone
(26) 4–methyl-alpha-pyrrolidinobutyrophenone
(27) 2–(methylamino)–1–phenylpropan–1–one
(28) 4–ethylmethcathinone
(29) 3,4–Dimethylmethcathinone
(30) alpha–Pyrrolidinopentiophenone
(31) beta–Keto–Ethylbenzodioxolylbutanamine
(32) 3,4–methylenedioxy–N–ethylcathinone.
(f) Unless specifically excepted or listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or cannabimimetic agents within the structural classes identified below:
(1) 2–(3–hydroxycyclohexyl) phenol with substitution at the 5–position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent;
(2) 3–(1–naphthoyl) indole or 3–(1–naphthyl) indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent;
(3) 3–(1–naphthoyl) pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the naphthoyl ring to any extent;
(4) 1–(1–naphthylmethyl) indene by substitution of the 3–position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent;
(5) 3–phenylacetylindole or 3–benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent;
(6) 5–(1,1–dimethylheptyl)–2–[(1R,3S)–3–hydroxycyclohexyl]–phenol (CP–47,497);
(7) 5–(1,1–dimethyloctyl)–2–[(1R,3S)–3–hydroxycyclohexyl]–phenol (cannabicyclohexanol or CP–47,497 C8–homolog);
(8) 1–pentyl–3–(1–naphthoyl) indole (JWH–018 and AM678);
(9) 1–butyl–3–(1–naphthoyl) indole (JWH–073);
(10) 1–hexyl–3–(1–naphthoyl) indole (JWH–019);
(11) 1–[2–(4–morpholinyl)ethyl]–3–(1–naphthoyl) indole (JWH–200);
(12) 1–pentyl–3–(2–methoxyphenylacetyl) indole (JWH–250);
(13) 1–pentyl–3–[1–(4–methoxynaphthoyl)] indole (JWH–081);
(14) 1–pentyl–3–(4–methyl–1–naphthoyl) indole (JWH–122);
(15) 1–pentyl–3–(4–chloro–1–naphthoyl) indole (JWH–398);
(16) 1–(5–fluoropentyl)–3–(1–naphthoyl) indole (AM2201);
(17) 1–(5–fluoropentyl)–3–(2–iodobenzoyl) indole (AM694);
(18) 1–pentyl–3–[(4–methoxy)–benzoyl] indole (SR–19 and RCS–4);
(19) 1–cyclohexylethyl–3–(2–methoxyphenylacetyl) indole (SR–18 and RCS–8); and
(20) 1–pentyl–3–(2–chlorophenylacetyl) indole (JWH–203).
CLASS D
(a)
(1) Barbital
(2) Chloral betaine
(3) Chloral hydrate
(4) Ethchlorvynol
(5) Ethinamate
(6) Methohexital
(7) Meprobamate
(8) Methylphenobarbital
(9) Paraldehyde
(10) Petrichloral
(11) Phenobarbital
(b) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following substances, or which contains any of their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Marihuana
(2) Butyl Nitrite
(3) Isobutyl Nitrite
(4) 1–Nitrosoxy–Methyl–Propane.
CLASS E
(a) Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams
(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams
(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams
(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit
(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams
(b) Prescription drugs other than those included in Classes A, B, C, D, and subsection (a) of this Class.

Structure Massachusetts General Laws

Massachusetts General Laws

Part I - Administration of the Government

Title XV - Regulation of Trade

Chapter 94c - Controlled Substances Act

Section 1 - Definitions

Section 2 - Establishment of Schedules of Drugs or Other Controlled Substances

Section 2a - Temporary Placement of Substance in Schedule I

Section 3 - Findings Required for Placement in Schedules

Section 4 - Exceptions From Schedules

Section 5 - Dispensing Controlled Substances Excepted Under Sec. 4

Section 6 - Rules and Regulations

Section 6a - Licensure of Certain Corporate Entities With Patients Receiving Opioid Agonist Therapy; Best Practice Guidance for Practitioners

Section 7 - Registration of Persons Who Manufacture, Distribute, Dispense or Possess Controlled Substances

Section 7a - Registration as Participant in Prescription Monitoring Program

Section 8 - Research Projects and Studies

Section 9 - Administering and Dispensing of Controlled Substances in Course of Professional Practice; Records, Inspection

Section 10 - Separate Registration

Section 11 - Inspection of Establishments of Registrants or Applicants

Section 12 - Issuance of Registration to Manufacture or Distribute Controlled Substances

Section 13 - Suspension or Revocation of Registration; Report of Criminal Violations; Controlled Substances Affected Placed Under Embargo; Forfeiture; Notice to Bureau

Section 14 - Suspension of or Refusal to Renew Registration Pending Proceedings in Cases of Imminent Danger to Public

Section 15 - Record-Keeping and Inventory Requirements; Filing of Dea Form 106 With City, Town and State Police Departments Upon Discovery of Theft or Loss of Controlled Substance

Section 16 - Distribution Between Registrants; Order Form

Section 17 - Necessity of Prescription for Dispensing Controlled Substances

Section 18 - Issuance of Prescription by Practitioner or Physician

Section 18a - Prerequisites for Issuing Outpatient Extended-Release Long-Acting Opioid in a Non-Abuse Deterring Form; Written Pain Management Treatment Plan for Long-Term Pain Management

Section 18b - Voluntary Non-Opiate Directive Form

Section 18c - Patient Education Required Before Issuance of Opioid Prescription

Section 19 - Prescription; Restrictions on Issuance

Section 19a - Emergency Contraception

Section 19b - Dispensing, Possessing and Administrating Opioid Antagonist

Section 19b1/2 - Exchange of Naloxone or Other Opioid Antagonist Between Registered Entities

Section 19c - High Opiate Overdose Area Pharmacies Required to Maintain Continuous Supply of Naloxone Rescue Kits or Opioid Antagonist Medications

Section 19d - Supply Limitations for Opiate Prescriptions; Exception for Palliative Care

Section 20 - Oral Prescriptions

Section 20a - Radiopharmaceutical Drugs

Section 21 - Packaging and Labeling by Pharmacist Filling Prescription; Distribution of Educational Pamphlet

Section 21a - Prescriptions; Prospective Drug Review and Counseling by Pharmacist

Section 21b - Advertisement and Sale of Prescription Lock Boxes by Pharmacies

Section 22 - Contents of Prescription Written by Practitioner

Section 23 - Written or Electronic Prescriptions; Requirements and Restrictions

Section 24 - Dispensing by Practitioner for Narcotic Drug Research or Treatment of Drug Dependent Persons

Section 24a - Electronic Monitoring of the Prescribing and Dispensing of Controlled Substances and Certain Additional Drugs

Section 24b - Mean and Median Quantity and Volume of Prescriptions for Opiates; Notification of Practitioner's Own Percentile Ranking

Section 25 - Restrictions

Section 26 - Distribution in Course of Business in Violation of Sec. 16 or Furnishing False Information in Application, etc., Prohibited

Section 27 - Sale of Hypodermic Syringes or Hypodermic Needles

Section 27a - Collection and Disposal of Spent Non-Commercially Generated Hypodermic Needles and Lancets

Section 28 - Jurisdiction of Superior Court

Section 29 - Educational Programs for Prevention of Abuse of Controlled Substances

Section 30 - Administrative Inspection of Controlled Premises

Section 31 - Classes of Controlled Substances; Establishment of Criminal Penalties for Violations of This Chapter

Section 32 - Class a Controlled Substances; Unlawful Manufacture, Distribution, Dispensing or Possession With Intent to Manufacture, etc.; Eligibility for Parole

Section 32a - Class B Controlled Substances; Unlawful Manufacture, Distribution, Dispensing or Possession With Intent to Manufacture, Etc.

Section 32b - Class C Controlled Substances; Unlawful Manufacturer, Distribution, Dispensing or Possession With Intent to Manufacture, Etc.

Section 32c - Class D Controlled Substances; Unlawful Manufacture, Distribution, Dispensing, Cultivation or Possession With Intent to Manufacture, Etc.

Section 32d - Class E Controlled Substances; Unlawful Manufacture, Distribution, Dispensing, or Possession With Intent to Manufacture, Etc.

Section 32e - Trafficking in Marihuana, Cocaine, Heroin, Synthetic Opioids, Morphine, Opium, etc.; Eligibility for Parole

Section 32f - Unlawful Manufacture, Distribution, Dispensing or Possession With Intent to Manufacture, Etc. of Controlled Substances in Classes a to C to Minors

Section 32g - Counterfeit Substances; Unlawful Creation, Distribution, Dispensing or Possession With Intent to Distribute or Dispense

Section 32h - Prosecutions Not to Be Continued or Placed on File; Suspension or Reduction of Sentence; Eligibility for Parole, Etc.

Section 32h1/2 - Good Behavior Deductions From Sentence After Serving Mandatory Minimum Term of Imprisonment; Eligibility; Parole; Work Release

Section 32i - Drug Paraphernalia; Sale, Possession or Manufacture With Intent to Sell; Penalty; Sale of Tobacco Rolling Papers

Section 32j - Controlled Substances Violations In, on or Near School Property or Public Parks or Playgrounds

Section 32k - Inducing or Abetting Minor to Distribute or Sell Controlled Substances

Section 32l - Possession of 2 Ounces or Less of Marihuana; Civil Penalty and Forfeiture; Other Sanctions or Disqualifications Prohibited

Section 32m - Possession of 2 Ounces or Less of Marihuana; Drug Awareness Program

Section 32n - Possession of One Ounce or Less of Marihuana; Enforcement Consistent With Non-Criminal Disposition Provisions of Sec. 21d of Chapter 40; Duty of Police Department; Notice; Failure to File Certificate of Completion of Drug Awareness Prog...

Section 33 - Unlawful Use of Registration Numbers in Manufacture or Distribution, or Fraudulently Obtaining Possession, of Controlled Substances; Criminal Penalties

Section 34 - Unlawful Possession of Particular Controlled Substances, Including Heroin and Marijuana; Lawful Possessing, Storing, Analyzing, Processing and Testing of Medical Marijuana and Medical Marijuana-Infused Products by Laboratories Exception

Section 34a - Immunity From Prosecution Under Sec. 34 or Finding of Violation of Condition of Probation, Pretrial Release or Parole for Persons Seeking Medical Assistance for Self or Other Experiencing Drug-Related Overdose

Section 36 - Protective Custody of Children Found Present Where Controlled Substances Are Unlawfully Kept or Possessed

Section 37 - Theft of Controlled Substances From Persons Authorized to Dispense or Possess

Section 38 - Violation of Secs. 24(a), 25, 26 or 27

Section 39 - Violation of Secs. 21 or 22

Section 40 - Conspiracy

Section 41 - Arrest Without Warrant

Section 42 - Cooperation With Federal and Other State Agencies

Section 43 - Conformity With Federal Acts

Section 44 - Violations of Sec. 34; Acquittal, Dismissal or Indictment Nol Prossed; Sealing of Records

Section 45 - Photographing and Fingerprinting of Persons Charged With Felony

Section 47 - Forfeiture of Property

Section 47a - Seized Controlled Substances and Narcotic Drugs; Custodian; Mailing for Chemical Analysis; Destruction or Disposal Upon Completion of Trial

Section 48 - Severability

Section 49 - Enforcement of Sec. 24a